OBJECTIVE: To examine the association between regional brain uptake of a novel amyloid positron emission tomography (PET) tracer florbetapir F 18 ([(18)F]-AV-45) and cognitive performance in a pilot study. DESIGN: Cross-sectional comparison of [(18)F]-AV-45 in AD patients versus controls. SETTING: Three specialty memory clinics. PARTICIPANTS: Eleven participants with probable Alzheimer disease (AD) by NINDS/ADRDA criteria and 15 healthy comparison (HC) participants. MEASUREMENTS: Participants underwent PET imaging following a 370 MBq (10 mCi) intravenous administration of [(18)F]-AV-45. Regional/cerebellar standardized uptake value ratios (SUVRs) were calculated. Cognition was assessed using Mini-Mental State Examination, Alzheimer's Disease Assessment Scale-Cognitive subscale (ADAS-Cog), Wechsler Logical Memory IA (immediate recall) test (LMIA), and verbal category fluency. RESULTS: Greater [(18)F]-AV-45 SUVR was associated with poorer performance on all cognitive tests. In the HC group, occipital, parietal, precuneus, temporal, and cortical average SUVR was associated with greater ADAS-Cog, and greater anterior cingulate SUVR was associated with lower LMIA. Two HC participants had [(18)F]-AV-45 cortical/cerebellar SUVR greater than 1.5, one of whom had deficits in episodic recall and on follow-up met criteria for amnestic mild cognitive impairment. CONCLUSION: [(18)F]-AV-45 SUVR in several brain regions was associated with worse global cognitive performance particularly in HC, suggesting its potential as a marker of preclinical AD.
OBJECTIVE: To examine the association between regional brain uptake of a novel amyloid positron emission tomography (PET) tracer florbetapir F 18 ([(18)F]-AV-45) and cognitive performance in a pilot study. DESIGN: Cross-sectional comparison of [(18)F]-AV-45 in ADpatients versus controls. SETTING: Three specialty memory clinics. PARTICIPANTS: Eleven participants with probable Alzheimer disease (AD) by NINDS/ADRDA criteria and 15 healthy comparison (HC) participants. MEASUREMENTS: Participants underwent PET imaging following a 370 MBq (10 mCi) intravenous administration of [(18)F]-AV-45. Regional/cerebellar standardized uptake value ratios (SUVRs) were calculated. Cognition was assessed using Mini-Mental State Examination, Alzheimer's Disease Assessment Scale-Cognitive subscale (ADAS-Cog), Wechsler Logical Memory IA (immediate recall) test (LMIA), and verbal category fluency. RESULTS: Greater [(18)F]-AV-45 SUVR was associated with poorer performance on all cognitive tests. In the HC group, occipital, parietal, precuneus, temporal, and cortical average SUVR was associated with greater ADAS-Cog, and greater anterior cingulate SUVR was associated with lower LMIA. Two HC participants had [(18)F]-AV-45 cortical/cerebellar SUVR greater than 1.5, one of whom had deficits in episodic recall and on follow-up met criteria for amnestic mild cognitive impairment. CONCLUSION: [(18)F]-AV-45 SUVR in several brain regions was associated with worse global cognitive performance particularly in HC, suggesting its potential as a marker of preclinical AD.
Authors: William J Jagust; Dan Bandy; Kewei Chen; Norman L Foster; Susan M Landau; Chester A Mathis; Julie C Price; Eric M Reiman; Daniel Skovronsky; Robert A Koeppe Journal: Alzheimers Dement Date: 2010-05 Impact factor: 21.566
Authors: Timo Grimmer; Gjermund Henriksen; Hans-Jürgen Wester; Hans Förstl; William E Klunk; Chester A Mathis; Alexander Kurz; Alexander Drzezga Journal: Neurobiol Aging Date: 2008-03-17 Impact factor: 4.673
Authors: S M Resnick; J Sojkova; Y Zhou; Y An; W Ye; D P Holt; R F Dannals; C A Mathis; W E Klunk; L Ferrucci; M A Kraut; D F Wong Journal: Neurology Date: 2010-02-10 Impact factor: 9.910
Authors: Gaël Chételat; Victor L Villemagne; Pierrick Bourgeat; Kerryn E Pike; Gareth Jones; David Ames; Kathryn A Ellis; Cassandra Szoeke; Ralph N Martins; Graeme J O'Keefe; Olivier Salvado; Colin L Masters; Christopher C Rowe Journal: Ann Neurol Date: 2010-03 Impact factor: 10.422
Authors: Seok Rye Choi; Geoff Golding; Zhiping Zhuang; Wei Zhang; Nathaniel Lim; Franz Hefti; Tyler E Benedum; Michael R Kilbourn; Daniel Skovronsky; Hank F Kung Journal: J Nucl Med Date: 2009-10-16 Impact factor: 10.057
Authors: William E Klunk; Henry Engler; Agneta Nordberg; Yanming Wang; Gunnar Blomqvist; Daniel P Holt; Mats Bergström; Irina Savitcheva; Guo-feng Huang; Sergio Estrada; Birgitta Ausén; Manik L Debnath; Julien Barletta; Julie C Price; Johan Sandell; Brian J Lopresti; Anders Wall; Pernilla Koivisto; Gunnar Antoni; Chester A Mathis; Bengt Långström Journal: Ann Neurol Date: 2004-03 Impact factor: 10.422
Authors: A Okello; J Koivunen; P Edison; H A Archer; F E Turkheimer; K Någren; R Bullock; Z Walker; A Kennedy; N C Fox; M N Rossor; J O Rinne; D J Brooks Journal: Neurology Date: 2009-07-08 Impact factor: 9.910
Authors: Dorene M Rentz; Joseph J Locascio; John A Becker; Erin K Moran; Elisha Eng; Randy L Buckner; Reisa A Sperling; Keith A Johnson Journal: Ann Neurol Date: 2010-03 Impact factor: 10.422
Authors: Reisa A Sperling; Keith A Johnson; P Murali Doraiswamy; Eric M Reiman; Adam S Fleisher; Marwan N Sabbagh; Carl H Sadowsky; Alan Carpenter; Mat D Davis; Ming Lu; Matthew Flitter; Abhinay D Joshi; Christopher M Clark; Michael Grundman; Mark A Mintun; Daniel M Skovronsky; Michael J Pontecorvo Journal: Neurobiol Aging Date: 2012-08-09 Impact factor: 4.673
Authors: Angie C A Chiang; Stephanie W Fowler; Rohit Reddy; Olga Pletnikova; Juan C Troncoso; Mathew A Sherman; Sylvain E Lesne; Joanna L Jankowsky Journal: Am J Pathol Date: 2017-12-15 Impact factor: 4.307
Authors: Effie M Mitsis; Heidi A Bender; Lale Kostakoglu; Josef Machac; Jane Martin; Jennifer L Woehr; Margaret C Sewell; Amy Aloysi; Martin A Goldstein; Clara Li; Mary Sano; Sam Gandy Journal: Mol Neurodegener Date: 2014-02-03 Impact factor: 14.195
Authors: Milos D Ikonomovic; Chris J Buckley; Kerstin Heurling; Paul Sherwin; Paul A Jones; Michelle Zanette; Chester A Mathis; William E Klunk; Aruna Chakrabarty; James Ironside; Azzam Ismail; Colin Smith; Dietmar R Thal; Thomas G Beach; Gill Farrar; Adrian P L Smith Journal: Acta Neuropathol Commun Date: 2016-12-12 Impact factor: 7.801
Authors: Sarah C McEwen; David A Merrill; Jennifer Bramen; Verna Porter; Stella Panos; Scott Kaiser; John Hodes; Aarthi Ganapathi; Lesley Bell; Tess Bookheimer; Ryan Glatt; Molly Rapozo; Mary Kay Ross; Nathan D Price; Daniel Kelly; Cory C Funk; Leroy Hood; Jared C Roach Journal: Alzheimers Dement (N Y) Date: 2021-07-20